BWNB Q1 2026 Earnings Significant EPS Miss Triggers Negative Market Response PLSE Q1 2026 Earnings EPS Beat but No Revenue as Stock Declines Maximus MMS Q1 2026 Earnings EPS Beats Estimates Stock Slightly Down Verrica Pharmaceuticals Q1 2026 Earnings EPS Miss Amid PreRevenue Stage Stock Rises 271 Federated Hermes Inc FHI Q1 2026 Earnings EPS Surpasses Estimates by 63 FORA Q1 2026 Earnings Steep EPS Miss Overshadows Quarter as Revenue Remains Undisclosed